Free Trial
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel Free IINN Stock Alerts

Inspira Technologies OXY B.H.N. (IINN) Competitors

Inspira Technologies OXY B.H.N. logo
$1.29 -0.23 (-15.13%)
As of 06/12/2026
Compare

IINN vs. SMTI, PDEX, TLSI, APYX, and RXST

Should you buy Inspira Technologies OXY B.H.N. stock or one of its competitors? MarketBeat compares Inspira Technologies OXY B.H.N. with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Inspira Technologies OXY B.H.N. include Sanara MedTech (SMTI), Pro-Dex (PDEX), TriSalus Life Sciences (TLSI), Apyx Medical (APYX), and RxSight (RXST). These companies are all part of the "medical equipment" industry.

How does Inspira Technologies OXY B.H.N. compare to Sanara MedTech?

Sanara MedTech (NASDAQ:SMTI) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Sanara MedTech.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sanara MedTech$103.12M1.85-$37.56M-$3.77N/A
Inspira Technologies OXY B.H.N.$289K160.46-$13.22MN/AN/A

Sanara MedTech currently has a consensus target price of $34.00, indicating a potential upside of 63.38%. Given Sanara MedTech's stronger consensus rating and higher probable upside, equities research analysts clearly believe Sanara MedTech is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanara MedTech
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

8.1% of Sanara MedTech shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 42.0% of Sanara MedTech shares are owned by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Sanara MedTech had 3 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 4 mentions for Sanara MedTech and 1 mentions for Inspira Technologies OXY B.H.N.. Sanara MedTech's average media sentiment score of 1.19 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Sanara MedTech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sanara MedTech
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Sanara MedTech has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its stock price is 116% more volatile than the broader market.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Sanara MedTech's net margin of -31.23%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Sanara MedTech's return on equity.

Company Net Margins Return on Equity Return on Assets
Sanara MedTech-31.23% -3.19% -0.56%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Summary

Sanara MedTech and Inspira Technologies OXY B.H.N. tied by winning 7 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Pro-Dex?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 15.3% of Pro-Dex shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Comparatively, 45.9% of Pro-Dex shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its share price is 116% more volatile than the broader market. Comparatively, Pro-Dex has a beta of -0.02, meaning that its share price is 102% less volatile than the broader market.

Pro-Dex has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K160.46-$13.22MN/AN/A
Pro-Dex$66.59M2.98$8.98M$3.6217.18

In the previous week, Pro-Dex had 2 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 3 mentions for Pro-Dex and 1 mentions for Inspira Technologies OXY B.H.N.. Pro-Dex's average media sentiment score of 0.85 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Pro-Dex is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Pro-Dex
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Pro-Dex has a net margin of 16.08% compared to Inspira Technologies OXY B.H.N.'s net margin of 0.00%. Pro-Dex's return on equity of 22.78% beat Inspira Technologies OXY B.H.N.'s return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
Pro-Dex 16.08%22.78%14.30%

Pro-Dex has a consensus target price of $70.00, indicating a potential upside of 12.54%. Given Pro-Dex's stronger consensus rating and higher probable upside, analysts clearly believe Pro-Dex is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Pro-Dex
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

Pro-Dex beats Inspira Technologies OXY B.H.N. on 12 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to TriSalus Life Sciences?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations and institutional ownership.

TriSalus Life Sciences has a consensus price target of $7.50, indicating a potential upside of 98.94%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, analysts clearly believe TriSalus Life Sciences is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
TriSalus Life Sciences
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its stock price is 116% more volatile than the broader market. Comparatively, TriSalus Life Sciences has a beta of 0.49, meaning that its stock price is 51% less volatile than the broader market.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to TriSalus Life Sciences' net margin of -60.85%.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
TriSalus Life Sciences -60.85%N/A -69.91%

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than TriSalus Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K160.46-$13.22MN/AN/A
TriSalus Life Sciences$45.15M5.13-$39.23M-$1.41N/A

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 2.6% of TriSalus Life Sciences shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Comparatively, 16.3% of TriSalus Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, TriSalus Life Sciences had 7 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 8 mentions for TriSalus Life Sciences and 1 mentions for Inspira Technologies OXY B.H.N.. TriSalus Life Sciences' average media sentiment score of 0.21 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that TriSalus Life Sciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
TriSalus Life Sciences
0 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Inspira Technologies OXY B.H.N. beats TriSalus Life Sciences on 7 of the 13 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and media sentiment.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Apyx Medical's net margin of -16.40%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Apyx Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Apyx Medical-16.40% -88.47% -14.94%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Apyx Medical has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its stock price is 116% more volatile than the broader market.

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 15.2% of Apyx Medical shares are held by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Apyx Medical and Apyx Medical both had 1 articles in the media. Apyx Medical's average media sentiment score of 1.89 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Apyx Medical is being referred to more favorably in the media.

Company Overall Sentiment
Apyx Medical Very Positive
Inspira Technologies OXY B.H.N. Neutral

Apyx Medical has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apyx Medical$52.84M3.72-$11.21M-$0.22N/A
Inspira Technologies OXY B.H.N.$289K160.46-$13.22MN/AN/A

Apyx Medical presently has a consensus target price of $6.50, indicating a potential upside of 38.59%. Given Apyx Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Apyx Medical is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Apyx Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Apyx Medical beats Inspira Technologies OXY B.H.N. on 8 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to RxSight?

RxSight (NASDAQ:RXST) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than RxSight.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RxSight$127.48M1.53-$38.94M-$1.13N/A
Inspira Technologies OXY B.H.N.$289K160.46-$13.22MN/AN/A

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to RxSight's net margin of -36.58%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat RxSight's return on equity.

Company Net Margins Return on Equity Return on Assets
RxSight-36.58% -17.01% -15.12%
Inspira Technologies OXY B.H.N. N/A N/A N/A

RxSight has a beta of 1.14, suggesting that its share price is 14% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its share price is 116% more volatile than the broader market.

78.8% of RxSight shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 10.1% of RxSight shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

RxSight currently has a consensus target price of $9.44, indicating a potential upside of 100.52%. Given RxSight's stronger consensus rating and higher probable upside, equities analysts clearly believe RxSight is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RxSight
3 Sell rating(s)
10 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.93
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, RxSight and RxSight both had 1 articles in the media. RxSight's average media sentiment score of 1.89 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that RxSight is being referred to more favorably in the media.

Company Overall Sentiment
RxSight Very Positive
Inspira Technologies OXY B.H.N. Neutral

Summary

Inspira Technologies OXY B.H.N. beats RxSight on 7 of the 13 factors compared between the two stocks.

Get Inspira Technologies OXY B.H.N. News Delivered to You Automatically

Sign up to receive the latest news and ratings for IINN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IINN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IINN vs. The Competition

Export
MetricInspira Technologies OXY B.H.N.MED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$46.37M$7.04B$6.52B$12.05B
Dividend YieldN/A1.21%2.67%5.66%
P/E RatioN/A47.8824.0024.42
Price / Sales160.4682.35533.77123.88
Price / CashN/A25.5927.4837.92
Price / Book21.506.8410.556.82
Net Income-$13.22M$159.20M$3.57B$337.56M
7 Day Performance-9.15%-0.93%0.59%1.16%
1 Month Performance226.58%5.15%1.55%3.16%
1 Year Performance77.71%1.23%25.41%30.60%

Inspira Technologies OXY B.H.N. Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IINN
Inspira Technologies OXY B.H.N.
0.538 of 5 stars		$1.29
-15.1%		N/A+77.7%$46.37M$289KN/A20
SMTI
Sanara MedTech
2.1339 of 5 stars		$22.99
+1.2%		$34.00
+47.9%		-27.8%$208.21M$103.12MN/A60
PDEX
Pro-Dex
2.9446 of 5 stars		$61.98
-4.6%		$70.00
+12.9%		+57.2%$207.53M$66.59M17.12140
TLSI
TriSalus Life Sciences
3.5039 of 5 stars		$3.55
+6.3%		$7.50
+111.3%		-27.4%$205.13M$45.15MN/A106
APYX
Apyx Medical
2.6063 of 5 stars		$4.61
-5.1%		$6.50
+41.0%		+168.0%$203.51M$52.84MN/A270

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:IINN) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel